Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
2. 3-ethyl 5-methyl (4s)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate Benzenesulfonate (1:1)
1. 150566-71-5
2. (s)-amlodipine Besylate
3. Levamlodipine Besilate
4. (-)-amlodipine Besylate
5. Levamlodipine Besilate [who-dd]
6. S-amlodipine Benzenesulfonate
7. Levoamlodipine Besylate
8. 885h5yc40l
9. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
10. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Monobenzenesulfonate
11. Benzenesulfonic Acid;3-o-ethyl 5-o-methyl (4s)-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
12. 3,5-pyridinedicarboxylic Acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
13. Unii-885h5yc40l
14. (s)-amlodipinebesylate
15. Hy-14744a
16. Cs-0090891
17. 129l824
18. Q27269892
19. (s)-amlodipine Besylate (103129-82-4(free Base))
20. 192583-58-7
Molecular Weight | 567.1 g/mol |
---|---|
Molecular Formula | C26H31ClN2O8S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 11 |
Exact Mass | 566.1489648 g/mol |
Monoisotopic Mass | 566.1489648 g/mol |
Topological Polar Surface Area | 163 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 830 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Nepal
Brand Name : YESAMLO
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Nepal
Regulatory Info :
Registration Country : Nepal
Brand Name : YESAMLO
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Nepal
Regulatory Info :
Registration Country : India
Olmesartan Medoxomil; (S)-Amlodipine
Brand Name :
Dosage Form : Tablet
Dosage Strength : 20MG; 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Olmesartan Medoxomil; (S)-Amlodipine
Brand Name :
Dosage Form : Tablet
Dosage Strength : 20MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging : 2.5mgx7tabs; 2.5mgx7tabsx2plates
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?